The musculoskeletal manifestations of Psoriatic arthritis (PsA) impose a significant burden on patients by impacting their quality of life and increasing mortality. The recommendations developed by European League Against Rheumatism (EULAR) focus on the management of musculoskeletal manifestations of the illness. To discuss the recommendations on IL-17 inhibitors by EULAR, Lilly Immunology and Docplexus have organized an interactive LIVE webinar on 29th July 2020, Wednesday at 03:30 PM GST.
Join the expert, Associate Professor Tue Wenzel Kragstrup as he discusses the topic- EULAR Recommendations For Psoriatic Arthritis: Where Do Anti-IL17s Fit In The Treatment Algorithm . The agenda of this webinar is as follows: Explanation of the new PsA Recommendations, with a focus on the changes for the IL-17 class + Short Recap of the main H2H data Patient Case illustrating the new…
